OUR FUTURE HEALTH
The advancement of health in the UK for the public benefit
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net expenditure loss of £12.9m for the year ended 31 March 2025, resulting in unrestricted reserves decreasing from £44.0m to £31.0m. Per the trustees' report, the organization maintains a strong surplus against its stated reserves policy target of three months of committed costs less committed revenues, supported by a healthy year-end cash position of £10.6m.
What the accounts disclose
“£340,001 - £350,000 1”
“Of the employees whose emoluments exceed £60,000, 138 (2024: 76) have retirement benefits accruing under defined contribution schemes.” — page 25
“Income from government grants 54,160,200”
“Our Future Health will maintain a target level of free reserves equivalent to at least three months of committed costs less committed revenues.”
“Our Future Health also has a wholly owned trading subsidiary which is limited by share capital. The trading subsidiary is called Our Future Health Trading Ltd (company number 12599493)”
Funders the charity credits
- Asthma + Lung UK
- Alnylam
UK research funding (UKRI Gateway to Research)
- Accelerating Detection of Disease Core Programme (1 April 2023 onwards)
- Rhythms in Disease- Determining Circadian Clock Mechanism in Asthma
- Consolidating the UK Longitudinal Linkage Collaboration for the longitudinal research community.
- UK Longitudinal Linkage Collaboration: the transformative Trusted Research Environment for the UK longitudinal research community
- GENETIC VARIATION, IRON AND LATER LIFE HEALTH OUTCOMES
- SOCGEN: Combining Social Science and Molecular Genetic Research to Examine Inequality and the Life Course
- Health Research from Home: advancing population research using smartphones and wearables
- Population Research UK Coordination Hub
- Cohort and Longitudinal Studies Enhancement Resources (CLOSER) - 1 October 2024 to 30 September 2028
- The Avon Longitudinal Study of Parents and Children (ALSPAC) 2024-2029
Advertised salaries (public job ads)
- Director of Data Operations and Governance
- Senior Agile Coach
- Engineering Manager
- General Counsel
- Staff Software Engineer - Data Platforms
- Software Engineer - (Typescript & Node)
- Senior Data Engineer
- Senior Commercial Strategy & Insights Analyst
Structured financials (annual return, FY ending 31/03/2025)
Trustees
- Professor Sir John Irving Bellchair
- Adrian Nevil Hennah
- Ciaran Martin CB
- Dr Glenn Wells
- Dr Timothy Charles Peakman
- John Deanfield
- Kemal Zulfiqar Malik
- MARY-JANE CALAM
- Peter Alan Chambre
- Professor Sir Harpal Singh Kumar
- Richard George Sexton
- Sally Osman
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £97.9m | £110.9m |
| 31/03/2024 | £80.3m | £85.4m |
| 31/03/2023 | £26.5m | £35.7m |
| 31/03/2022 | £64.8m | £6.5m |
| 31/03/2021 | £4.4m | £4.4m |
Common questions
Is OUR FUTURE HEALTH financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net expenditure loss of £12.9m for the year ended 31 March 2025, resulting in unrestricted reserves decreasing from £44.0m to £31.0m. Per the trustees' report, the organization maintains a strong surplus against its stated reserves policy target of three months of committed costs less committed revenues, supported by a healthy year-end cash position of £10.6m. Its FY2025 accounts were audited by Saffery LLP.
What does the highest-paid employee of OUR FUTURE HEALTH earn?
Per its FY2025 accounts, the highest-paid employee was in the £340,001 - £350,000 band, and 138 employees earned over £60,000.
Who funds OUR FUTURE HEALTH?
Funders whose own accounts filings name OUR FUTURE HEALTH as a grant recipient include BRITISH HEART FOUNDATION, Asthma and Lung UK.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| BRITISH HEART FOUNDATION | FY2025 | £5.0m | Research |
| Asthma and Lung UK | FY2024 | £90k | Non-Research grant |
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| UK government | 22/01/2024 | £54.2m | Accelerating Detection of Disease Core Programme (1 April 2023 onwards) |
| UK government | 22/01/2024 | £62.0m | Accelerating Detection of Disease Core Programme (1 April 2023 onwards) |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE MOHN WESTLAKE FOUNDATION | 1 | £1.0m |
| THE HEALTH FOUNDATION | 1 | £496k |
| THE NUFFIELD FOUNDATION | 1 | £382k |
| THE PEARS FAMILY CHARITABLE FOUNDATION | 1 | £300k |
| BEIS MENACHEM CHABAD LUBAVITCH | 1 | £183k |
| JOHN ELLERMAN FOUNDATION | 1 | £150k |
| THE DULVERTON TRUST | 1 | £145k |
| Tinsley Charitable Trust | 1 | £40k |
Charities like this
- SUSTAINABILITY. HEALTH. ENVIRONMENT. DEVELOPMENT.
- THE BRITISH FRIENDS OF ZICHRON MENACHEM
- YOUR VOICE IN HEALTH AND SOCIAL CARE
- YAD VEACHISOMOCH L'CHAIM
- FULL FACT
- NEW FUTURES NEPAL LIMITED
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| OUR FUTURE HEALTH | £97.9m | £340,001 - £350,000 | 138 | unclear | — | no doubt |
| SUSTAINABILITY. HEALTH. ENVIRONMENT. DEVELOPMENT. | £2.8m | — | 0 | above | — | no doubt |
| THE BRITISH FRIENDS OF ZICHRON MENACHEM | £152k | — | 0 | unclear | — | no doubt |
| YOUR VOICE IN HEALTH AND SOCIAL CARE | £1.2m | — | 0 | unclear | — | no doubt |
| YAD VEACHISOMOCH L'CHAIM | £834k | — | 0 | unclear | — | no doubt |
| FULL FACT | £2.9m | — | — | within | — | no doubt |